Antisense Therapeutics Limited Stock Price on October 30, 2024
| ATHJF Stock | USD 0.04 0.00 0.00% |
If you're considering investing in Antisense Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Antisense Therapeutics stands at 0.04, as last reported on the 13th of December 2024, with the highest price reaching 0.04 and the lowest price hitting 0.04 during the day. Antisense Therapeutics is out of control given 3 months investment horizon. Antisense Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We are able to break down seventeen different technical indicators, which can help you to evaluate if expected returns of 4.8% are justified by taking the suggested risk. Use Antisense Therapeutics Standard Deviation of 39.12, mean deviation of 9.72, and Risk Adjusted Performance of 0.0948 to evaluate company specific risk that cannot be diversified away.
Antisense Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Antisense |
Sharpe Ratio = 0.1198
| Best Portfolio | Best Equity | ATHJF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 40.04 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.8 actual daily | 95 95% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Antisense Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Antisense Therapeutics by adding it to a well-diversified portfolio.
Antisense Therapeutics Valuation on October 30, 2024
It is possible to determine the worth of Antisense Therapeutics on a given historical date. On October 30, 2024 Antisense was worth 0.0566 at the beginning of the trading date compared to the closed value of 0.0566. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Antisense Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Antisense Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Antisense Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Antisense Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.06 | 0.06 | 0.06 | 0.06 | 1.00 | |
10/30/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1.00 |
| 0.06 | 0.06 | 0.06 | 0.06 | 1.00 |
| Backtest Antisense Therapeutics | | | Antisense Therapeutics History | | | Antisense Therapeutics Valuation | Previous | Next |
Antisense Therapeutics Trading Date Momentum on October 30, 2024
| On October 31 2024 Antisense Therapeutics Limited was traded for 0.06 at the closing time. The highest daily price throughout the period was 0.06 and the lowest price was 0.06 . There was no trading activity during the period 1.0. Lack of trading volume on 10/31/2024 did not affect price variability. The overall trading delta to current closing price is 25.80% . |
Antisense Therapeutics Fundamentals Correlations and Trends
By evaluating Antisense Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Antisense Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Antisense financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Antisense Therapeutics Pink Sheet history
Antisense Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Antisense is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Antisense Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Antisense Therapeutics stock prices may prove useful in developing a viable investing in Antisense Therapeutics
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Antisense Therapeutics Pink Sheet Technical Analysis
Antisense Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Antisense Therapeutics Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Antisense Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Antisense Therapeutics December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Antisense Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Antisense Therapeutics shares will generate the highest return on investment. By undertsting and applying Antisense Therapeutics pink sheet market strength indicators, traders can identify Antisense Therapeutics Limited entry and exit signals to maximize returns
Antisense Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Antisense Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Antisense Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Antisense to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0948 | |||
| Jensen Alpha | 3.71 | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | 0.543 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Antisense Pink Sheet analysis
When running Antisense Therapeutics' price analysis, check to measure Antisense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antisense Therapeutics is operating at the current time. Most of Antisense Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antisense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antisense Therapeutics' price. Additionally, you may evaluate how the addition of Antisense Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |